Live
- Sudanese army recaptures capital of Sinnar State in central Sudan
- Kishkindha Kaandam Review: Some movies prove not to compromise in having a good cinematic experience and this is one of them
- Son-rise: Hemant Soren grows taller as tribal leader, makes father proud
- ISL 2024-25: 10-man NorthEast United FC hold on to take three points vs Punjab FC
- BGT 2024-25: Jaiswal’s application, commitment to form a partnership was so impressive, says Gilchrist
- BGT 2024-25: Personally, I am very happy with my performance, says Harshit Rana
- Pakistan's Lahore remains world's most polluted city despite light drizzle
- Asha Nautiyal retains Kedarnath for BJP, to be back as MLA after 12 years
- India leads world in science, innovation research: Minister
- Flash flood in Indonesia's South Tapanuli claims two lives
Hyderabad: Balaxi Pharma posts Rs 10 crore net in Q2
Balaxi Pharma posts Rs 10 crore net in Q2
City-based Balaxi Pharmaceuticals Limited (BPL) reported Rs 60.3 crore revenue for the second quarter ended September 2020
Hyderabad: City-based Balaxi Pharmaceuticals Limited (BPL) reported Rs 60.3 crore revenue for the second quarter ended September 2020. It reported an EBITDA of Rs 10.3 crore and a net profit of Rs 10.1 crore during the period.
During the first half of current fiscal, it posted a total revenue of Rs 112.4 crore. The EBITDA stood Rs 19.3 crore while net profit came at Rs 18.8 crore. Ashish Maheshwari, company's Chairman and Managing Director, said: "We are delighted to report a decent growth in our business amidst Covid-19 pandemic.
The company has 548 pharmaceutical product registrations spanning across five countries and 582 product registrations in pipeline.
We also have a well-established expert regulatory team, which carefully monitors the registration process at every stage. We aim to double our pharmaceutical product registrations over next 2 years."
